Skip to main content

Bionano Genomics, Inc.

BNGO
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
SEC CIK
0001411690

In the last 90 days, Bionano Genomics, Inc. insiders filed 2 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q3 2026, worth $4.21M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 17, 2026
$13.3M
Insider buysLast 90 days, $9.70K in total
2
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, +1 vs. previous quarter
35
13F valueReported value at the end of Q3 2026
$4.21M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$28.5M
−7.4% year over year
Net income, FY2025
-$26.4M
No comparable prior period
Free cash flow, FY2025
–
No comparable prior period
Revenue, Q3 FY2026
$8.28M
+12.3% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $26.4M (92.6% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
1.39M
Shares sold short
Change
+27.6K
+2.0% vs. previous
Days to cover
7.39
At average daily volume

Superinvestors holding BNGO, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding BNGO at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Bionano Genomics, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 9, 2026 (view filing)4:30 PM ETSep 45 daysLuderer AlbertInterim Chief ExecutivePPurchase+4.00K$1.21+$4.84K+100.0%8.00K after
Aug 21, 2026 (view filing)4:30 PM ETAug 21Same dayLuderer AlbertInterim Chief ExecutivePPurchase+4.00K$1.22+$4.86KNew position4.00K after
Jun 14, 2023 (view filing)Jun 131 dayMamuszka HannahDirectorPPurchase+65.8K$0.76+$50.0KNew position65.8K after
May 16, 2023 (view filing)May 16Same dayHolmlin R. ErikPresident and CEOPPurchase+15.0K$0.64+$9.60K+1.9%806.5K after
May 16, 2023 (view filing)May 124 daysStewart Christopher P.Chief Financial OfficerPPurchase+50.0K$0.67+$33.5K+21.6%281.4K after
Aug 17, 2022 (view filing)5:55 PM ETAug 152 daysLinney YvonneDirectorSSale−20.0K$3.62−$72.4K−100.0%0 after
May 18, 2022 (view filing)May 162 daysBarker David LDirectorPPurchase+10.0K$1.60+$16.0K+256.8%13.9K after
Dec 1, 2021 (view filing)Nov 292 daysHolmlin R. ErikPresident and CEOPPurchase+5.03K$3.99+$20.0KNew position5.03K after3 lots

Top 10 13F holders, Q3 2026

See all 35 holders

The largest institutional positions in Bionano Genomics, Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding BNGO in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
AIGH Capital Management LLC1,165,000$1.82M0.21%+1,165,000New
Two Sigma Investments, LP483,557$754.3K0.00%+483,557New
Renaissance Technologies LLC154,000$240.2K0.00%+102,900+201.4%Added
Vanguard Capital Management LLC138,786$216.5K0.00%+56,398+68.5%Added
Carret Asset Management, LLC135,545$211.4K0.02%+10,545+8.4%Added
HRT Financial LP96,866$151.0K0.00%+85,126+725.1%Added
Gsa Capital Partners LLP92,384$144.0K0.01%−57,900−38.5%Reduced
Acadian Asset Management LLC89,186$137.0K0.00%+89,186New
Jane Street Group, LLC86,321$134.7K0.00%+50,593+141.6%Added
Geode Capital Management, LLC77,274$120.5K0.00%−12,719−14.1%Reduced

Holders of 5% or more of BNGO

See all 5 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bionano Genomics, Inc..

Largest holders of BNGO from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Ayrton Capital LLC13G9.99%528.2K sharesNewNov 13, 20251 filingNov 13, 2025SEC
CVI Investments, Inc.13G/A9.90%1.50M shares0.00 ppfrom 9.90%Jan 13, 20256 filingsNov 16, 2026SEC
Hirschman Orin13G9.90%1.17M sharesNewOct 19, 20261 filingOct 19, 2026SEC
Lind Global Fund III LP13G/A9.35%1.05M shares−0.55 ppfrom 9.90%Sep 24, 20253 filingsFeb 17, 2026SEC
Lincoln Alternative Strategies LLC13G5.42%525.0K sharesNewSep 17, 20251 filingSep 17, 2025SEC